May 26, 2026

Eli Lilly Buys 3 Vaccine Companies in $3.8 Billion Deal to Expand Infectious Disease Push

The drugmaker said the acquisitions target shingles, antibiotic-resistant bacteria, and Epstein-Barr virus.